Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Current measures effective for variants

    By WANG XIAOYU | CHINA DAILY | Updated: 2022-07-22 09:08
    Share
    Share - WeChat
    An asymptomatic carrier of COVID-19 (center) waves goodbye to medical workers at a makeshift hospital after finishing his medical observation in Zhangye, Gansu province, on Wednesday. He will undergo a seven-day health monitoring at home. [Photo by WANG JIANG/FOR CHINA DAILY]

    Early detection underlined in latest guideline to tackle Omicron strain

    China's COVID-19 disease control measures can effectively tackle the BA.4 and BA.5 subvariants of Omicron, and existing vaccines can offer protection against the two highly contagious strains, a public health expert said on Thursday.

    Dong Xiaoping, chief virologist at the Chinese Center for Disease Control and Prevention, said during a news conference that the BA.4 and BA.5 strains are more transmissible than other subvariants of Omicron, but their pathogenicity-meaning the virus' ability to attack human bodies-currently shows no major difference from other strains.

    With BA.4 and BA.5 variants having become dominant in some regions and triggered fresh infection spikes in parts of Europe and America, he said the incidence and mortality rates of the disease will likely rise, citing results of epidemiological models.

    "However, there is no evidence to show that non-pharmaceutical interventions (such as mask wearing and keeping social distance) will no longer work," he said. "In other words, China's current virus containment measures remain effective."

    To better cope with the highly transmissible and stealthy Omicron strain, Dong said the latest disease control guideline, issued by the National Health Commission in late June, has underscored early detection of the virus.

    "The new guideline has clarified monitoring rules for high-risk workers, added drugs into its monitoring system and used antigen tests as an additional tool," he said. "Deployment of such new strategies and technologies will greatly boost our capability to identify Omicron cases."

    Research into upgraded COVID-19 vaccines tailored to emerging strains is underway, according to Dong, but more time is needed to roll out third-stage human trials and decide on whether to replace current vaccines based on the original strain.

    Dong noted that some in-vitro experiments demonstrate that the effects of neutralizing antibodies generated following immunization on the two new strains decreased, but whether the protection of existing vaccines will diminish in real-world cases is unclear.

    "Domestic and foreign experts believe that current vaccines remain effective, and getting vaccinated and, in particular, boosted, is still the best approach to fend off the virus for the elderly and those with underlying diseases," he said.

    As of Wednesday, China had fully vaccinated nearly 89.7 percent of its population and 84.5 percent of people aged 60 and above, according to the National Health Commission.

    Dong added that the novel coronavirus will continue to mutate for a long time and Omicron won't be the last mutation. "We will focus on monitoring new strains as well as their transmissibility, pathogenicity and ability to evade immunity," he said.

    On the mainland, 21 provincial-level regions had reported new locally transmitted infections in the past week, some being caused by BA.4 or BA.5.

    He Qinghua, an official with the commission's bureau of disease prevention and control, said that new outbreaks in Gansu and Henan provinces, as well as the Guangxi Zhuang autonomous region are developing.

    "Most domestic infection clusters can be contained in a short period and the epidemic's impact is limited," he said. "The capability and efficiency of local disease control work has improved."

    On Wednesday, the mainland reported 148 locally transmitted, confirmed infections and 678 asymptomatic cases, compared with 108 and 827 respectively for the previous day.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    国产仑乱无码内谢| 日韩中文字幕在线播放| √天堂中文官网在线| 免费无码又爽又刺激高潮视频| 中文字幕亚洲综合精品一区| 99国产精品无码| 亚洲人成无码网站在线观看| 久久精品中文闷骚内射| 色视频综合无码一区二区三区| 久久丝袜精品中文字幕| 国产精品久久久久无码av| 亚洲av永久无码精品漫画 | 少妇人妻偷人精品无码视频| 日本中文字幕在线电影| 涩涩色中文综合亚洲| 国产真人无码作爱免费视频| 久久国产精品无码HDAV| 无码精品黑人一区二区三区| 久久亚洲AV无码精品色午夜| 狠狠精品久久久无码中文字幕| 亚洲中文字幕无码久久综合网| 蜜臀精品无码AV在线播放| 久久亚洲AV成人无码国产| 亚洲va无码手机在线电影| 中文字幕人妻无码系列第三区| 精品久久久久中文字| 最新中文字幕在线观看| 中文字幕一区一区三区| 大蕉久久伊人中文字幕| 狠狠综合久久综合中文88| 日本高清免费中文在线看| 欧美日韩国产中文精品字幕自在自线 | 无码日韩精品一区二区三区免费| 国产成人AV一区二区三区无码| 亚洲精品中文字幕无码蜜桃| 无码人妻久久一区二区三区蜜桃| 亚洲精品欧美二区三区中文字幕| 最近2019年免费中文字幕高清| 中文字幕在线视频播放| 中文无码vs无码人妻| 一区二区三区人妻无码 |